Published in N Engl J Med on March 30, 2006
Live, attenuated influenza A H5N1 candidate vaccines provide broad cross-protection in mice and ferrets. PLoS Med (2006) 3.71
Broad Clade 2 cross-reactive immunity induced by an adjuvanted clade 1 rH5N1 pandemic influenza vaccine. PLoS One (2008) 2.18
Potent immunity to low doses of influenza vaccine by probabilistic guided micro-targeted skin delivery in a mouse model. PLoS One (2010) 1.27
Preparedness for highly pathogenic avian influenza pandemic in Africa. Emerg Infect Dis (2007) 1.25
5'PPP-RNA induced RIG-I activation inhibits drug-resistant avian H5N1 as well as 1918 and 2009 pandemic influenza virus replication. Virol J (2010) 1.02
Safety and immunogenicity of H5N1 influenza vaccine based on baculovirus surface display system of Bombyx mori. PLoS One (2008) 1.01
The first influenza pandemic of the 21st century. Ann Saudi Med (2010) 0.94
In vitro responses to avian influenza H5 by human CD4 T cells. J Immunol (2009) 0.91
Avian influenza: the tip of the iceberg. Ann Thorac Med (2008) 0.88
Safety, humoral and cell mediated immune responses to two formulations of an inactivated, split-virion influenza A/H5N1 vaccine in children. PLoS One (2008) 0.86
The spatial resolution of epidemic peaks. PLoS Comput Biol (2014) 0.85
Zoonoses, One Health and complexity: wicked problems and constructive conflict. Philos Trans R Soc Lond B Biol Sci (2017) 0.77
Protection from avian influenza H5N1 virus infection with antibody-impregnated filters. Virol J (2011) 0.77
An inactivated subvirion influenza A (H5N1) vaccine. N Engl J Med (2006) 0.77
Repeated Low-Dose Influenza Virus Infection Causes Severe Disease in Mice: a Model for Vaccine Evaluation. J Virol (2015) 0.75
Hybrid inorganic-organic capsules for efficient intracellular delivery of novel siRNAs against influenza A (H1N1) virus infection. Sci Rep (2017) 0.75
Safety and immunogenicity of an inactivated subvirion influenza A (H5N1) vaccine. N Engl J Med (2006) 9.73
Score tests for association between traits and haplotypes when linkage phase is ambiguous. Am J Hum Genet (2001) 22.07
Myopericarditis following smallpox vaccination among vaccinia-naive US military personnel. JAMA (2003) 2.15
3' tag digital gene expression profiling of human brain and universal reference RNA using Illumina Genome Analyzer. BMC Genomics (2009) 2.12
Developing the next generation of vaccinologists. Vaccine (2010) 2.07
Immunosenescence: role and measurement in influenza vaccine response among the elderly. Vaccine (2007) 1.78
2009 H1N1 influenza. Mayo Clin Proc (2009) 1.76
The contribution of HLA class I antigens in immune status following two doses of rubella vaccination. Hum Immunol (2004) 1.70
Detection of smallpox virus DNA by LightCycler PCR. J Clin Microbiol (2002) 1.62
Associations between SNPs in toll-like receptors and related intracellular signaling molecules and immune responses to measles vaccine: preliminary results. Vaccine (2008) 1.60
Human leukocyte antigen haplotypes in the genetic control of immune response to measles-mumps-rubella vaccine. J Infect Dis (2006) 1.54
Influenza vaccination among registered nurses: information receipt, knowledge, and decision-making at an institution with a multifaceted educational program. Infect Control Hosp Epidemiol (2008) 1.50
Rubella vaccine-induced cellular immunity: evidence of associations with polymorphisms in the Toll-like, vitamin A and D receptors, and innate immune response genes. Hum Genet (2009) 1.46
Assessing participation bias in a population-based study of measles-mumps-rubella vaccine immunity in children and adolescents aged 12-18. Paediatr Perinat Epidemiol (2007) 1.45
Independence of measles-specific humoral and cellular immune responses to vaccination. Hum Immunol (2012) 1.44
If you could halve the mortality rate, would you do it? Clin Infect Dis (2002) 1.42
Human leukocyte antigen and cytokine receptor gene polymorphisms associated with heterogeneous immune responses to mumps viral vaccine. Pediatrics (2008) 1.41
The association of CD46, SLAM and CD209 cellular receptor gene SNPs with variations in measles vaccine-induced immune responses: a replication study and examination of novel polymorphisms. Hum Hered (2011) 1.40
Confronting bioterrorism: physicians on the front line. Mayo Clin Proc (2002) 1.40
Asthma and the immune response to MMR vaccine viruses in Somali immigrant children: a cross-sectional retrospective cohort study. Prim Care Respir J (2013) 1.40
Revised SHEA position paper: influenza vaccination of healthcare personnel. Infect Control Hosp Epidemiol (2010) 1.39
Gender effects on humoral immune responses to smallpox vaccine. Vaccine (2009) 1.39
Zoster vaccine recommendations: the importance of using a clinically valid correlate of protection. Vaccine (2011) 1.39
Methodologic reporting requirements for clinical trials: advancing the science today and tomorrow. Vaccine (2011) 1.37
Immunization and the prevention of influenza and pneumococcal disease in people with diabetes. Diabetes Care (2003) 1.35
Associations between measles vaccine immunity and single-nucleotide polymorphisms in cytokine and cytokine receptor genes. J Infect Dis (2006) 1.35
Human leukocyte antigen class II alleles and rubella-specific humoral and cell-mediated immunity following measles-mumps-rubella-II vaccination. J Infect Dis (2005) 1.35
Polymorphisms in the vitamin A receptor and innate immunity genes influence the antibody response to rubella vaccination. J Infect Dis (2010) 1.31
2'-5'-Oligoadenylate synthetase single-nucleotide polymorphisms and haplotypes are associated with variations in immune responses to rubella vaccine. Hum Immunol (2010) 1.30
HLA class II alleles and measles virus-specific cytokine immune response following two doses of measles vaccine. Immunogenetics (2005) 1.28
Associations between single nucleotide polymorphisms and haplotypes in cytokine and cytokine receptor genes and immunity to measles vaccination. Vaccine (2011) 1.24
Variations in measles vaccine-specific humoral immunity by polymorphisms in SLAM and CD46 measles virus receptors. J Allergy Clin Immunol (2007) 1.24
Genome-wide association study of antibody response to smallpox vaccine. Vaccine (2012) 1.23
Immunization programs for infants, children, adolescents, and adults: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis (2009) 1.22
Development of a novel efficient fluorescence-based plaque reduction microneutralization assay for measles virus immunity. Clin Vaccine Immunol (2008) 1.21
Calculating sample size estimates for RNA sequencing data. J Comput Biol (2013) 1.21
Hepatitis B vaccine nonresponse and celiac disease. Am J Gastroenterol (2003) 1.20
A large observational study to concurrently assess persistence of measles specific B-cell and T-cell immunity in individuals following two doses of MMR vaccine. Vaccine (2011) 1.18
Human leukocyte antigen genotypes in the genetic control of adaptive immune responses to smallpox vaccine. J Infect Dis (2011) 1.18
Systems biology approaches to new vaccine development. Curr Opin Immunol (2011) 1.17
The role of polymorphisms in Toll-like receptors and their associated intracellular signaling genes in measles vaccine immunity. Hum Genet (2011) 1.17
Replication of rubella vaccine population genetic studies: validation of HLA genotype and humoral response associations. Vaccine (2009) 1.17
Genome-wide analysis of polymorphisms associated with cytokine responses in smallpox vaccine recipients. Hum Genet (2012) 1.15
SNP/haplotype associations in cytokine and cytokine receptor genes and immunity to rubella vaccine. Immunogenetics (2010) 1.15
Immunologic significance of HLA class I genes in measles virus-specific IFN-gamma and IL-4 cytokine immune responses. Immunogenetics (2005) 1.13
Genetic polymorphisms in host antiviral genes: associations with humoral and cellular immunity to measles vaccine. Vaccine (2011) 1.12
Influenza and pneumococcal immunization in diabetes. Diabetes Care (2004) 1.11
Influence of host genetic variation on rubella-specific T cell cytokine responses following rubella vaccination. Vaccine (2009) 1.10
HLA supertypes and immune responses to measles-mumps-rubella viral vaccine: findings and implications for vaccine design. Vaccine (2007) 1.10
Frequency of measles virus-specific CD4+ and CD8+ T cells in subjects seronegative or highly seropositive for measles vaccine. Clin Diagn Lab Immunol (2003) 1.10
Vaccinating health care workers against influenza: the ethical and legal rationale for a mandate. Am J Public Health (2011) 1.10
The immunology of smallpox vaccines. Curr Opin Immunol (2009) 1.10
Influenza vaccines: from surveillance through production to protection. Mayo Clin Proc (2010) 1.09
Response surface methodology to determine optimal cytokine responses in human peripheral blood mononuclear cells after smallpox vaccination. J Immunol Methods (2008) 1.09
Cytokine production patterns and antibody response to measles vaccine. Vaccine (2003) 1.09
H5N1 Avian influenza: preventive and therapeutic strategies against a pandemic. Annu Rev Med (2010) 1.09
Childhood asthma and measles vaccine response. Ann Allergy Asthma Immunol (2006) 1.09
Common SNPs/haplotypes in IL18R1 and IL18 genes are associated with variations in humoral immunity to smallpox vaccination in Caucasians and African Americans. J Infect Dis (2011) 1.09
Measles virus receptors: SLAM and CD46. Rev Med Virol (2004) 1.09
The genetic basis for interindividual immune response variation to measles vaccine: new understanding and new vaccine approaches. Expert Rev Vaccines (2013) 1.08
Genome-wide genetic associations with IFNγ response to smallpox vaccine. Hum Genet (2012) 1.08
A taxonomy of reasoning flaws in the anti-vaccine movement. Vaccine (2007) 1.07
Predominant inflammatory cytokine secretion pattern in response to two doses of live rubella vaccine in healthy vaccinees. Cytokine (2010) 1.06
HLA homozygosity does not adversely affect measles vaccine-induced cytokine responses. Virology (2007) 1.06
Relationship between HLA polymorphisms and gamma interferon and interleukin-10 cytokine production in healthy individuals after rubella vaccination. Clin Vaccine Immunol (2007) 1.06
Detection of measles virus-specific interferon-gamma-secreting T-cells by ELISPOT. Methods Mol Biol (2005) 1.05
Facing the challenges of influenza in healthcare settings: the ethical rationale for mandatory seasonal influenza vaccination and its implications for future pandemics. Vaccine (2008) 1.04
Statistical approach to estimate vaccinia-specific neutralizing antibody titers using a high-throughput assay. Clin Vaccine Immunol (2009) 1.04
Consistency of HLA associations between two independent measles vaccine cohorts: a replication study. Vaccine (2012) 1.03
Extended LTA, TNF, LST1 and HLA gene haplotypes and their association with rubella vaccine-induced immunity. PLoS One (2010) 1.03
Interleukin-4 induced by measles virus and measles-derived peptides as measured by IL-4 receptor-blocking ELISA. J Immunol Methods (2004) 1.03
Technical and biological variance structure in mRNA-Seq data: life in the real world. BMC Genomics (2012) 1.03
Vaccination policies for health-care workers in acute health-care facilities in Europe. Vaccine (2011) 1.02
Studies of twins in vaccinology. Vaccine (2007) 1.02
Human leukocyte antigen and interleukin 2, 10 and 12p40 cytokine responses to measles: is there evidence of the HLA effect? Cytokine (2007) 1.02
Understanding the immune response to seasonal influenza vaccination in older adults: a systems biology approach. Expert Rev Vaccines (2012) 1.01
Avian influenza vaccines: what's all the flap? Lancet (2006) 1.01
Variation in vaccine response in normal populations. Pharmacogenomics (2004) 1.00
Advances in the vaccination of the elderly against influenza: role of a high-dose vaccine. Expert Rev Vaccines (2010) 1.00
Extinction of the human leukocyte antigen homozygosity effect after two doses of the measles-mumps-rubella vaccine. Hum Immunol (2005) 1.00
Accurate mass precursor ion data and tandem mass spectrometry identify a class I human leukocyte antigen A*0201-presented peptide originating from vaccinia virus. J Am Soc Mass Spectrom (2005) 1.00
Associations between SNPs in candidate immune-relevant genes and rubella antibody levels: a multigenic assessment. BMC Immunol (2010) 1.00
Association of parental vaccination reports with measles, mumps, and rubella protective antibody levels: comparison of Somali immigrant, Hispanic migrant, and US children in Rochester, Minn. Mayo Clin Proc (2002) 0.99
Associations between human leukocyte antigen (HLA) alleles and very high levels of measles antibody following vaccination. Vaccine (2004) 0.99
Associations between human leukocyte antigen homozygosity and antibody levels to measles vaccine. J Infect Dis (2002) 0.98
T-Cell epitope discovery for variola and vaccinia viruses. Rev Med Virol (2007) 0.98
Effects of vitamin A and D receptor gene polymorphisms/haplotypes on immune responses to measles vaccine. Pharmacogenet Genomics (2012) 0.98
Fear, misinformation, and innumerates: how the Wakefield paper, the press, and advocacy groups damaged the public health. Vaccine (2010) 0.98
The association of class I HLA alleles and antibody levels after a single dose of measles vaccine. Hum Immunol (2003) 0.97
Human leukocyte antigen polymorphisms: variable humoral immune responses to viral vaccines. Expert Rev Vaccines (2006) 0.97
Discovery of naturally processed and HLA-presented class I peptides from vaccinia virus infection using mass spectrometry for vaccine development. Vaccine (2009) 0.96
High-throughput assay optimization and statistical interpolation of rubella-specific neutralizing antibody titers. Clin Vaccine Immunol (2014) 0.96
Hepatitis B DNA vaccine induces protective antibody responses in human non-responders to conventional vaccination. Vaccine (2003) 0.96
TAP1, TAP2, and HLA-DR2 alleles are predictors of cervical cancer risk. Gynecol Oncol (2003) 0.96
Impact of cytokine and cytokine receptor gene polymorphisms on cellular immunity after smallpox vaccination. Gene (2012) 0.96
Pertussis outbreaks and pertussis vaccines: new insights, new concerns, new recommendations? Vaccine (2012) 0.96
Personalized vaccinology: one size and dose might not fit both sexes. Vaccine (2013) 0.95
Assessment of humoral and cell-mediated immune response to measles-mumps-rubella vaccine viruses among patients with asthma. Allergy Asthma Proc (2011) 0.95
Genome-wide characterization of transcriptional patterns in high and low antibody responders to rubella vaccination. PLoS One (2013) 0.95
Vaccine education spectrum disorder: the importance of incorporating psychological and cognitive models into vaccine education. Vaccine (2011) 0.95